title: Baicalin Inhibits Lipopolysaccharide-Induced Inflammation Through Signaling NF-κB Pathway in HBE16 Airway Epithelial Cells.
abstract: Baicalin, a flavonoid monomer derived from Scutellaria baicalensis called Huangqin in mandarin, is the main active ingredient contributing to S. baicalensis' efficacy. It is known in China that baicalin has potential therapeutic effects on inflammatory diseases. However, its anti-inflammatory mechanism has still not been fully interpreted. We aim to investigate the anti-inflammatory effect of baicalin on lipopolysaccharide (LPS)-induced inflammation in HBE16 airway epithelial cells and also to explore the underlying signaling mechanisms. The anti-inflammatory action of baicalin was evaluated in human airway epithelial cells HBE16 treated with LPS. Airway epithelial cells HBE16 were pretreated with a range of concentrations of baicalin for 30 min and then stimulated with 10 μg/ml LPS. The secretions of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-α (TNF-α) in cell culture supernatants were quantified by enzyme-linked immunosorbent assay (ELISA). The messenger RNA (mRNA) expressions of IL-6, IL-8, and TNF-α were tested by quantitative real-time polymerase chain reaction (real-time RT-PCR). Furthermore, Western blotting was used to determine whether the signaling pathway NF-κB was involved in the anti-inflammatory action of baicalin. The inflammatory cell model was successfully built with 10 μg/ml LPS for 24 h in our in vitro experiments. Both the secretions and the mRNA expressions of IL-6, IL-8, and TNF-α were significantly inhibited by baicalin. Moreover, the expression levels of phospho-IKKα/β and phospho-NF-κB p65 were downregulated, and the phospho-IκB-α level was upregulated by baicalin. These findings suggest that the anti-inflammatory properties of baicalin may be resulted from the inhibition of IL-6, IL-8, and TNF-α expression via preventing signaling NF-κB pathway in HBE16 airway epithelial cells. In addition, this study provides evidence to understand the therapeutic effects of baicalin on inflammatory diseases in clinical practice.
authors: Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, West China Medical School, Sichuan University, Chengdu, 610041, China, wumingshoujin@sina.com.
authors: Shou-jin
authors: SJ
authors: Dong
authors: Yun-qing
authors: YQ
authors: Zhong
authors: Wen-ting
authors: WT
authors: Lu
authors: Guan-hong
authors: GH
authors: Li
authors: Hong-li
authors: HL
authors: Jiang
authors: Bing
authors: B
authors: Mao
mesh_terms: D005419:Flavonoids / Q000494:pharmacology*; D006801:Humans; D007249:Inflammation / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control; D018836:Inflammation Mediators / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000037:antagonists & inhibitors / Q000633:toxicity*; D016328:NF-kappa B / Q000037:antagonists & inhibitors / Q000378:metabolism*; D020545:Respiratory Mucosa / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D031363:Scutellaria; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology
chemical_list: D005419:Flavonoids; D018836:Inflammation Mediators; D008070:Lipopolysaccharides; D016328:NF-kappa B; C038044:baicalin
references: Chest. 2014 May;145(5):1121-1133
references: 24798836
references: Eur Respir J. 2010 Jun;35(6):1209-15
references: 20513910
references: Subcell Biochem. 2010;53:153-71
references: 20593266
references: Mol Neurobiol. 2013 Aug;48(1):190-204
references: 23436141
references: Planta Med. 2010 Dec;76(17):2012-8
references: 21077025
references: Am J Physiol Lung Cell Mol Physiol. 2013 Feb 15;304(4):L276-86
references: 23275623
references: J Biol Chem. 2010 Jul 16;285(29):22299-307
references: 20460375
references: BMC Complement Altern Med. 2012 May 16;12:64
references: 22591709
references: Int J Mol Med. 2014 Aug;34(2):632-8
references: 24938929
references: Inflammation. 2011 Oct;34(5):463-70
references: 20859668
references: J Ethnopharmacol. 2014 Sep 29;155(3):1534-40
references: 25091464
references: Arch Virol. 2014 Dec;159(12):3269-78
references: 25078390
references: Am J Respir Cell Mol Biol. 2009 Dec;41(6):631-8
references: 19717810
references: Int Immunopharmacol. 2014 Nov;23(1):294-303
references: 25239813
references: Commun Integr Biol. 2014 May 16;7:e29053
references: 25136402
references: J Dent Res. 2011 Apr;90(4):417-27
references: 20940366
references: FEBS Lett. 2001 Jun 29;500(1-2):52-5
references: 11434925
references: Sci Rep. 2014 Jun 26;4:5452
references: 24965553
references: Toxicol Sci. 2013 Oct;135(2):265-76
references: 23824089
references: Inflammation. 2015 Feb;38(1):110-25
references: 25249339
references: FASEB J. 2009 Dec;23(12):4244-55
references: 19690214
references: J Ocul Pharmacol Ther. 2014 Oct;30(8):605-14
references: 25280175
references: J Tradit Chin Med. 2013 Aug;33(4):505-12
references: 24187873